Merck

AACR 2023 – Moderna's immunotherapeutic splash

EP Vantage

Wed, 03/22/23 - 10:03 am

AACR

Moderna Therapeutics

Allogene

AstraZeneca

Merck, Viatris agree to settle patent feud surrounding diabetes drugs

Endpoints

Mon, 03/20/23 - 04:30 pm

Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases

CP WIre

Sat, 03/18/23 - 03:37 pm

executive compensation

Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases

Sat, 03/18/23 - 03:35 pm

executive compensation

Merck's TIGIT fails in phase 2 Keytruda combo, notching another loss for the class

Fierce Biotech

Thu, 03/16/23 - 07:02 pm

non-small cell lung cancer

metastatic non-small cell lung cancer

Keytruda Unlocked: How Should Merck Proceed with Trials?

BioSpace

Tue, 03/14/23 - 11:19 am

Merck asks EMA to reevaluate rejected Covid-19 antiviral

Endpoints

Mon, 03/13/23 - 04:40 pm

Merck reports positive data from malignant pleural mesothelioma trial

Clinical Trials Arena

Mon, 03/13/23 - 10:01 am

Merck

Canadian Cancer Trials Group

clinical trials

Keytruda

mesothelioma

In PD-1 rivalry, Merck's Keytruda catches up with Opdivo in rare lung cancer type

Fierce Pharma

Fri, 03/10/23 - 11:20 am

Merck pays $50 million for early-stage Epstein-Barr vaccine

BioPharma Dive

Wed, 03/8/23 - 09:49 pm

Merck’s oral cholesterol-lowering drug shows similar efficacy to injectable predecessors as it moves to PhIII: #ACC23

Endpoints

Mon, 03/6/23 - 11:15 pm

FDA asks advisers to review Lynparza amid growing scrutiny of PARP drugs

BioPharma Dive

Sun, 03/5/23 - 03:08 pm

Spotlight – What is next in Nash

EP Vantage

Fri, 03/3/23 - 10:02 am

NASH

clinical trials

89Bio

Arrowhead Pharmaceuticals

Can-Fite BioPharma

Ewopharma

Hepagene Therapeutics

JNJ

Ligand Pharmaceuticals

Madrigal Pharmaceuticals

Merck

NGM Biopharmaceuticals

NorthSea Therapeutics

Novartis

Sagimet Biosciences

Terns Pharmaceuticals

Viking Therapeutics

AstraZeneca, Merck's Lynparza to face FDA panel in prostate cancer bid as PARP scrutiny escalates

Fierce Pharma

Thu, 03/2/23 - 11:02 pm

Merck reports two Phase 3 study misses for Keytruda

BioPharma Dive

Tue, 02/28/23 - 10:43 pm

Big-sellers from Merck, Novo and Lilly likely to face Medicare price negotiations: report

Fierce Pharma

Tue, 02/28/23 - 10:39 pm

Keytruda killer: Chipscreen bags Chinese rights to Biocytogen's bispecific antibody

Fierce Biotech

Tue, 02/28/23 - 09:56 am

cancer

Biocytogen

Chipscreen NewWay Biosciences

Merck

Keytruda

YH008

Warren urges US patent office to scrutinize Merck's efforts with Keytruda

Fierce Pharma

Thu, 02/23/23 - 04:25 pm

Merck’s COVID-19 treatment falls short in prevention study

BioPharma Dive

Tue, 02/21/23 - 04:53 pm

BioNTech touts differences with Moderna in race for cancer vaccines

Endpoints

Tue, 02/21/23 - 04:41 pm

Search form

You are here

Merck

Pages